Mostrar el registro sencillo del ítem

dc.contributor.author
Martínez Martín, Pablo  
dc.contributor.author
Rodríguez Blázquez, Carmen  
dc.contributor.author
Alvarez, Mario  
dc.contributor.author
Arakaki, Tomoko  
dc.contributor.author
Campos Arillo, Víctor  
dc.contributor.author
Chaná, Pedro  
dc.contributor.author
Fernández, William  
dc.contributor.author
Garretto, Nelida  
dc.contributor.author
Martínez Castrillo, Juan Carlos  
dc.contributor.author
Rodríguez Violante, Mayela  
dc.contributor.author
Serrano Dueñas, Marcos  
dc.contributor.author
Ballesteros, Diego  
dc.contributor.author
Rojo Abuin, Jose Manuel  
dc.contributor.author
Chaudhuri, Kallol Ray  
dc.contributor.author
Merello, Marcelo Jorge  
dc.date.available
2018-02-16T13:38:03Z  
dc.date.issued
2014-11  
dc.identifier.citation
Martínez Martín, Pablo; Rodríguez Blázquez, Carmen; Alvarez, Mario; Arakaki, Tomoko; Campos Arillo, Víctor; et al.; Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale; Wiley-liss, Div John Wiley & Sons Inc; Movement Disorders; 21; 1; 11-2014; 50-54  
dc.identifier.issn
0885-3185  
dc.identifier.uri
http://hdl.handle.net/11336/36592  
dc.description.abstract
Background Severity of PD is usually assessed by means of the motor and disability-based Hoehn and Yahr staging (HY), or clinician and patient global perceptions. Scores of more detailed assessments, as the MDS-UPDRS, have not been translated to a grading that allows assignment of score sections to severity levels. The objective of the present study is to determine cut-off points for PD severity levels based on the MDS-UPDRS. Methods International, observational study. Applied assessments were: HY, MDS-UPDRS, Clinical Impression for Severity Index, and Clinical and Patient Global Impression of Severity. The coincidence in severity level (mild, moderate, severe) of at least two clinical classifications plus the patient's gradation was considered “the criterion of severity”. Cut-off values for each MDS-UPDRS subscale was determined by triangulation of: 1) percentile 90 of the subscale total score; 2) receiver operating characteristic (ROC) analysis; and 3) ordinal logistic regression (OLR) model. Results Sample was composed of 452 consecutive PD patients without dementia, 55.3% males, age 65.1 ± 10.7 years and PD duration 8.7 ± 6.3 years. All HY stages were represented. The “criterion”, classified 275 patients (60.8% of the sample) as: mild PD, 149 (54.2%); moderate, 82 (29.8%); and severe, 44 (16%). The following MDS-UPDRS cut-off points between mild/moderate and moderate/severe levels were found: Part 1: 10/11 and 21/22; Part 2: 12/13 and 29/30; Part 3: 32/33 and 58/59; and Part 4: 4/5 and 12/13. Conclusion Cut-off points to classify PD patients as mild, moderate, or severe on the basis of their MDS-UPDRS scores are proposed.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Wiley-liss, Div John Wiley & Sons Inc  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Pisa Syndrome  
dc.subject
Mds-Updrs  
dc.subject
Parkinson'S Disease  
dc.subject
Teaching Neuroimages  
dc.subject.classification
Otras Ciencias de la Salud  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2018-02-14T19:28:16Z  
dc.journal.volume
21  
dc.journal.number
1  
dc.journal.pagination
50-54  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
New York  
dc.description.fil
Fil: Martínez Martín, Pablo. Universidad Carlos III de Madrid. Instituto de Salud; España  
dc.description.fil
Fil: Rodríguez Blázquez, Carmen. Universidad Carlos III de Madrid. Instituto de Salud; España  
dc.description.fil
Fil: Alvarez, Mario. Departamento de Trastornos del Movimiento y Neurodegeneración. La Habana; Cuba  
dc.description.fil
Fil: Arakaki, Tomoko. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Ramos Mejía"; Argentina. Universidad de Buenos Aires; Argentina  
dc.description.fil
Fil: Campos Arillo, Víctor. Hospital Xanit International. Málaga; España  
dc.description.fil
Fil: Chaná, Pedro. Universidad de Santiago de Chile; Chile  
dc.description.fil
Fil: Fernández, William. Universidad Nacional de Colombia; Colombia  
dc.description.fil
Fil: Garretto, Nelida. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Ramos Mejía"; Argentina. Universidad de Buenos Aires; Argentina  
dc.description.fil
Fil: Martínez Castrillo, Juan Carlos. Hospital Ramon y Cajal. Madrid; España  
dc.description.fil
Fil: Rodríguez Violante, Mayela. Instituto Nacional de Neurologia y Neurocirugia. Mexico DF; México  
dc.description.fil
Fil: Serrano Dueñas, Marcos. Pontificia Universidad Catolica del Ecuador; Ecuador  
dc.description.fil
Fil: Ballesteros, Diego. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina  
dc.description.fil
Fil: Rojo Abuin, Jose Manuel. Consejo Español de Investigaciones Científicas. Madrid; España  
dc.description.fil
Fil: Chaudhuri, Kallol Ray. King's College Hospital. Londres; Reino Unido  
dc.description.fil
Fil: Merello, Marcelo Jorge. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina  
dc.journal.title
Movement Disorders  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.parkreldis.2014.10.026  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://www.prd-journal.com/article/S1353-8020(14)00411-8/fulltext